Blog
Discover our latest articles and blogs
Screen Failure Reduction: Fix the Funnel, Not Just the Site
Screen failure reduction starts with diagnosing why candidates fail. Learn how to separate protocol causes from site causes and cut screening waste.
Protocol Deviation Reduction: A Practical Guide for Clinical Ops
How to cut protocol deviations at the source: simpler design, a deviation assessment plan, root cause analysis and risk-based oversight, with data and FDA guidance.
Study Closeout Automation: What to Automate and What to Keep Human
Study closeout automation for biotech sponsors: which closeout tasks to automate, which need human judgment, the regulatory guardrails, and a step plan.
IND Safety Reporting Workflow: Why 7 and 15 Day Clocks Differ
Build an IND safety reporting workflow for FDA’s 7 and 15 day deadlines, covering sponsor triage, committee oversight, follow up, and AEMS or eCTD filings.
eTMF Process Optimization: Set QC by Risk in 12 Weeks
Tie ICH E6(R3) expectations to QC tolerances, governed automation, and a 12 week eTMF roadmap for inspection ready execution with an embedded partner.
Clinical Vendor Handoffs: 6 Steps Sponsors Can Verify
Make clinical vendor handoffs decision ready with six acceptance steps, inspection evidence, named owners, and a documented sponsor transition.
Response Letter Automation: eCTD, ESG and FDA Checks for Biotech
See how U.S. biotech teams can automate FDA response drafts, connect eCTD and ESG workflows, and preserve human review and inspection readiness.
Contract Cycle Time: Governed AI for a 60 to 90 Day Biotech Pilot
Cut biotech contract delays with governed AI, templates, and routing rules. See how embedded expertise can speed complex workflows in a 60 to 90 day pilot.
Biotech Enrollment Rescue: AI Can Shorten the 7 to 10 Day Diagnostic
AI can compress diagnosis when data is ready. Triage sites, match recruitment tactics to capacity fixes, and manage a 30 to 90 day clinical trial rescue.